Africa put on alert!

The article explains the concern around the rise of AMR and the lack of medicines to combat drug-resistant pathogens, highlighting report’s key finding that the pipeline of antimicrobial projects is on the decline.

It also focuses on AMR’s disproportionate effect on Africa, where in many regions, high rates of drug-resistant infections are already putting a strain on health systems.

Jayasree K. Iyer, CEO of the Access to Medicine Foundation is quoted: “In parts of sub-Saharan Africa, nearly half of babies dying from neonatal sepsis are linked to drug resistance because standard antibiotics no longer work.”

“If innovation does not reach patients in Africa, infections that are treatable elsewhere will continue to be fatal,” she says.